Report #2851386

Received Jul 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MO
Recovered: Unknown
Vaccinated: Sep 13, 2024
Onset: Sep 13, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	—

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

She received first dose of September 13 2024, and has not had the second dose; Initial report received on 15-Jul-2025. A pharmacist reported that a 55-year-old female (race, ethnicity not provided) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization on 13-Sep-2024 and had not yet received the second dose. No medical history or concomitant medications were reported. On 13-Sep-2024, the patient received dose 1 of a hepatitis B vaccine ([HEPLISAV-B (lot #, expiration date, NDC #, route, and site not available). At the time of reporting, the patient had not received the second dose yet. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.